Detalles de la búsqueda
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439329
2.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38818978
3.
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Hematol Oncol
; 40(4): 704-715, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608183
4.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107338
5.
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.
Oncologist
; 17(5): 663-72, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22531362
6.
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
Ann Hematol
; 90(12): 1449-56, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21437586
7.
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Eur J Haematol
; 84(6): 474-83, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20331733
8.
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.
Respir Med Case Rep
; 31: 101115, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32670785
9.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Br J Haematol
; 144(5): 653-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036082
10.
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Clin Lymphoma Myeloma
; 8(5): 294-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18854284
11.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Haematologica
; 91(1): 133-6, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16434383
12.
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma.
Hematol J
; 5(4): 312-7, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15297847
13.
MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma.
Acta Haematol
; 122(1): 42-5, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19729888
14.
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Clin Lymphoma Myeloma Leuk
; 12(6): 423-32, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22981966
15.
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.
Leuk Lymphoma
; 52(5): 776-85, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21338282
16.
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Leuk Lymphoma
; 51(8): 1444-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20496998
17.
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Br J Haematol
; 136(5): 729-35, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17233770
18.
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Blood
; 108(7): 2159-64, 2006 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16763209
19.
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.
Eur J Haematol
; 72(1): 10-7, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14962257
20.
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy.
Eur J Haematol
; 72(6): 403-9, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15128418